203 related articles for article (PubMed ID: 20038188)
1. Combining machine learning and pharmacophore-based interaction fingerprint for in silico screening.
Sato T; Honma T; Yokoyama S
J Chem Inf Model; 2010 Jan; 50(1):170-85. PubMed ID: 20038188
[TBL] [Abstract][Full Text] [Related]
2. Novel method for generating structure-based pharmacophores using energetic analysis.
Salam NK; Nuti R; Sherman W
J Chem Inf Model; 2009 Oct; 49(10):2356-68. PubMed ID: 19761201
[TBL] [Abstract][Full Text] [Related]
3. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
[TBL] [Abstract][Full Text] [Related]
4. Virtual screening of cathepsin k inhibitors using docking and pharmacophore models.
Ravikumar M; Pavan S; Bairy S; Pramod AB; Sumakanth M; Kishore M; Sumithra T
Chem Biol Drug Des; 2008 Jul; 72(1):79-90. PubMed ID: 18498326
[TBL] [Abstract][Full Text] [Related]
5. Large-scale learning of structure-activity relationships using a linear support vector machine and problem-specific metrics.
Hinselmann G; Rosenbaum L; Jahn A; Fechner N; Ostermann C; Zell A
J Chem Inf Model; 2011 Feb; 51(2):203-13. PubMed ID: 21207929
[TBL] [Abstract][Full Text] [Related]
6. Improving VEGFR-2 docking-based screening by pharmacophore postfiltering and similarity search postprocessing.
Planesas JM; Claramunt RM; Teixidó J; Borrell JI; Pérez-Nueno VI
J Chem Inf Model; 2011 Apr; 51(4):777-87. PubMed ID: 21417262
[TBL] [Abstract][Full Text] [Related]
7. Ligand prediction from protein sequence and small molecule information using support vector machines and fingerprint descriptors.
Geppert H; Humrich J; Stumpfe D; Gärtner T; Bajorath J
J Chem Inf Model; 2009 Apr; 49(4):767-79. PubMed ID: 19309114
[TBL] [Abstract][Full Text] [Related]
8. Fuzzy pharmacophore models from molecular alignments for correlation-vector-based virtual screening.
Renner S; Schneider G
J Med Chem; 2004 Sep; 47(19):4653-64. PubMed ID: 15341481
[TBL] [Abstract][Full Text] [Related]
9. Classification of cytochrome P450 1A2 inhibitors and noninhibitors by machine learning techniques.
Vasanthanathan P; Taboureau O; Oostenbrink C; Vermeulen NP; Olsen L; Jørgensen FS
Drug Metab Dispos; 2009 Mar; 37(3):658-64. PubMed ID: 19056915
[TBL] [Abstract][Full Text] [Related]
10. Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking.
Huang SY; Zou X
Proteins; 2007 Feb; 66(2):399-421. PubMed ID: 17096427
[TBL] [Abstract][Full Text] [Related]
11. Machine learning in computational docking.
Khamis MA; Gomaa W; Ahmed WF
Artif Intell Med; 2015 Mar; 63(3):135-52. PubMed ID: 25724101
[TBL] [Abstract][Full Text] [Related]
12. Drug discovery using support vector machines. The case studies of drug-likeness, agrochemical-likeness, and enzyme inhibition predictions.
Zernov VV; Balakin KV; Ivaschenko AA; Savchuk NP; Pletnev IV
J Chem Inf Comput Sci; 2003; 43(6):2048-56. PubMed ID: 14632457
[TBL] [Abstract][Full Text] [Related]
13. Potency-directed similarity searching using support vector machines.
Wassermann AM; Heikamp K; Bajorath J
Chem Biol Drug Des; 2011 Jan; 77(1):30-8. PubMed ID: 21114788
[TBL] [Abstract][Full Text] [Related]
14. A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance.
Perola E; Walters WP; Charifson PS
Proteins; 2004 Aug; 56(2):235-49. PubMed ID: 15211508
[TBL] [Abstract][Full Text] [Related]
15. Prediction of factor Xa inhibitors by machine learning methods.
Lin HH; Han LY; Yap CW; Xue Y; Liu XH; Zhu F; Chen YZ
J Mol Graph Model; 2007 Sep; 26(2):505-18. PubMed ID: 17418603
[TBL] [Abstract][Full Text] [Related]
16. An efficient in silico screening method based on the protein-compound affinity matrix and its application to the design of a focused library for cytochrome P450 (CYP) ligands.
Fukunishi Y; Hojo S; Nakamura H
J Chem Inf Model; 2006; 46(6):2610-22. PubMed ID: 17125201
[TBL] [Abstract][Full Text] [Related]
17. Virtual screening of Abl inhibitors from large compound libraries by support vector machines.
Liu XH; Ma XH; Tan CY; Jiang YY; Go ML; Low BC; Chen YZ
J Chem Inf Model; 2009 Sep; 49(9):2101-10. PubMed ID: 19689138
[TBL] [Abstract][Full Text] [Related]
18. In silico fragment screening by replica generation (FSRG) method for fragment-based drug design.
Fukunishi Y; Mashimo T; Orita M; Ohno K; Nakamura H
J Chem Inf Model; 2009 Apr; 49(4):925-33. PubMed ID: 19354203
[TBL] [Abstract][Full Text] [Related]
19. FlexE: efficient molecular docking considering protein structure variations.
Claussen H; Buning C; Rarey M; Lengauer T
J Mol Biol; 2001 Apr; 308(2):377-95. PubMed ID: 11327774
[TBL] [Abstract][Full Text] [Related]
20. Application of machine learning to improve the results of high-throughput docking against the HIV-1 protease.
Klon AE; Glick M; Davies JW
J Chem Inf Comput Sci; 2004; 44(6):2216-24. PubMed ID: 15554692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
